Study of Reminder-Focused Positive Psychiatry for PTSD in Adolescents
This study is looking at a treatment called Reminder Focused Positive Psychiatry (RFPP) for young people aged 11 to 15 who have Posttraumatic Stress Disorder (PTSD). RFPP helps you learn to recognize and manage upsetting memories related to trauma. We are comparing RFPP to a relaxation therapy group. The goal is to see if RFPP can improve PTSD symptoms over 24 months. You can join if you have documented PTSD, are 11-15 years old, and can read and write in English. You cannot join if you have certain other health conditions like intellectual disabilities or seizure disorders. The study plans to enroll 60 participants, but its current recruitment status is unclear.
- Study design
- This study is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 60 participants aged 11-15 years old.
- What's involved
- Participants in the attentional control group will undergo telehealth relaxation therapy twice a week for 6 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is to examine the impact of the intervention on PTSD symptoms measured at 24 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- To examine the impact of RFPP intervention on core PTSD symptoms24 months
There will be a change in core PTSD symptoms (% ranged from 0-100) after 6-week RFPP intervention, compared to control group